“MOLECULAR MECHANISMS AND CLINICAL POSSIBILITIES OF IMMUNOTHERAPY FOR NEUROBLASTOMA IN CHILDREN”, Genetics and Mol. Res., May 2026, doi: 10.4238/edtmbk06.